Clinical Trials in New York

Showing 921-940 of 10,830 trials

Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

NCT05812274

The purpose of this trial is to study the effectiveness of the AprictyRxTM care service to improve treatment outcomes of ethnic/racial minority N.S.C.L.C. patients receiving standard of care immunotherapy, and reduce the frequency of healthcare system interactions.

Non Small Cell Lung Cancer

Columbia University30 participantsStarted May 2023

New York, New York, United States • New York, New York, United States • New York, New York, United States +1 more locations

ACTIVE_NOT_RECRUITINGPHASE1< 1 mile

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

NCT05838768

The main purpose of the study is to evaluate the safety and tolerability of HRO761 and identify the recommended dose(s), i.e., the optimal safe and active dose of HRO761 alone or in combination with pembrolizumab or irinotecan that can be given to patients who have cancers with specific molecular alterations called MSIhi (Microsatellite Instability-high) or dMMR (Mismatch Repair Deficient) that might work best to treat these specific cancer types and to understand how well HRO761 is able to treat those cancers.

MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers

Novartis Pharmaceuticals327 participantsStarted Jun 2023

Los Angeles, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +26 more locations

Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

Find Trials by Condition in New York

A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight

Human Models of Selective Insulin Resistance: Pancreatic Clamp

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Group Interventions for Breast Cancer Survivors

International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases

Treating Patients With Melanoma and ALK Alterations With Ensartinib

Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition

Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

Registry of the Patient Experience for Carpal Tunnel Release

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

ICG Fluorescence Imaging in Post-traumatic Infection

Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma